The biologic drug Enbrel has gotten the green light from an FDA advisory committee to treat moderate to severe plaque psoriasis in children and teens who have tried other psoriasis treatments. The FDA ...

THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., April 30, 2004 – Amgen (N), today announced that Enbrel® (etanercept) has been approved by the U.S. Food and Drug Ad ASDAQ: AMGN) and Wyeth ...

Amgen Inc. won U.S. approval Friday to market its rheumatoid arthritis drug Enbrel as a treatment for the skin disorder psoriasis. A Food and Drug Administration spokeswoman said Enbrel had been ...

HealthDay News — For patients with psoriasis, ixekizumab is associated with significant improvements in psoriasis symptoms, with itch severity improvements seen as early as week one, according to a ...

THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 4, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) today announced results from a new trial that demonstrated Enbrel® ...

The researchers reported data for effects on fatigue and depression, which had been secondary end points in a randomized, controlled clinical trial in 618 patients with moderate to severe psoriasis ...

Please provide your email address to receive an email when new articles are posted on . Etanercept monotherapy or a combination of etanercept and methotrexate had better psoriasis outcomes than ...

Extended exposure to the psoriasis medication etanercept does not appear to cause more infections or adverse events than placebo, and improvements in several measures of disease severity were observed ...

NEW YORK, July 31 (Praxis Press) Patients with psoriasis and psoriatic arthritis have increased concentrations of tumor necrosis factor in their skin lesions and joints. Mease and colleagues studied ...

Dec. 15, 2003 — Etanercept monotherapy had a favorable safety profile and significantly benefitted patients with psoriasis, according to the results of a randomized, placebo-controlled trial published ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Amgen’s supplemental biologics license application for expanded use of Enbrel for treating ...